Education
About Us
Working with TipRanks
Follow Us
Alector Inc (ALEC)
NASDAQ:ALEC
Latozinemab
Neurodegenerative Diseases
Phase III
Enrolling By Invitation
Continuation Study for Latozinemab
Oct 18, 2023
―
Al001
Amyotrophic Lateral Sclerosis
Phase II
Terminated
A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS
Sep 01, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Alector Inc (ALEC) have in its pipeline
ALEC is currently developing the following drugs: Latozinemab, Al001. These drug candidates are in various stages of clinical development as the company works toward FDA approval.